Coral Laboratories Ltd.

BSE: CORALAB524506ISIN INE683E01017

Healthcare
Pharmaceuticals

Share price

₹486.20-12.80 (-2.57%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹679.00
52W low: ₹360.00
Off 52W high: -28.39%
1M return: -13.47%
3M return: -13.53%
6M return: +15.71%
1Y return: -1.68%
20D avg volume: 1,563
50 DMA: ₹560.10
200 DMA: ₹506.13

Key ratios Standalone

Market cap: ₹173.70 Cr
Current price: ₹486.20
52W high / low: ₹679.00 / ₹360.00
Face value: ₹10.00
P/E: 9.04
P/B: 0.85
EPS (TTM): ₹53.76
Book value / share: ₹572.00
ROE: 9.44%
ROCE: 10.90%
Operating margin: 25.78%
Net margin: 18.19%
Debt / equity: 0.02
Net debt: ₹2.96 Cr
Interest cover: 136.94
Dividend yield: 0.41%
Dividend / share (TTM): ₹2.00
Payout: 3.72%
Cash conversion cycle: 169.7 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	29.62	26.48	21.56	19.04	18.82	28.14	22.99	32.23	31.66	—
	2.15	2.65	2.49	2.71	2.05	2.48	2.52	2.54	1.56	—
	31.77	29.13	24.06	21.74	20.87	30.62	25.51	34.77	33.22	—
	24.83	20.83	20.36	14.65	17.15	26.00	17.20	26.24	21.44	—
	9.71	11.30	12.93	7.31	8.33	11.39	8.98	15.97	11.80	—
	1.49	0.26	0.75	0.81	0.82	0.43	0.16	0.27	0.70	—
	4.29	4.39	4.40	3.70	3.42	3.83	3.38	3.93	3.59	—
	0.03	0.01	0.00	0.10	0.06	0.04	0.02	0.01	0.03	—
	0.66	0.54	0.69	0.45	0.45	0.51	0.50	0.51	0.49	—
	6.18	5.32	6.59	2.85	4.48	7.05	—	—	3.90	—
	6.94	8.30	3.70	7.09	3.72	4.62	8.31	8.53	11.78	—
	0.00	-0.01	0.00	0.32	0.00	-0.77	—	—	—	—
	6.94	8.29	3.70	7.42	3.72	3.85	8.31	8.53	11.78	—
	1.55	3.06	0.92	1.59	1.16	1.02	2.17	2.15	2.97	—
	5.39	5.22	2.78	5.82	2.56	2.83	6.14	6.38	8.80	—
	30.16	14.62	7.77	16.29	7.18	7.91	17.20	17.86	24.64	—
Key metrics
	7.63	8.84	4.39	7.97	4.23	4.40	8.83	9.05	12.30	—
	25.80%	33.40%	20.40%	41.90%	22.50%	15.60%	38.40%	28.10%	38.90%	—
	18.20%	19.70%	12.90%	30.60%	13.60%	10.10%	26.70%	19.80%	27.80%	—
	—	3.90%	—	3.50%	—	1.90%	—	—	—	—
	57.40%	-5.90%	-6.20%	-40.90%	-40.60%	—	—	—	—	—
	110.50%	84.50%	-54.70%	-8.80%	-70.90%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	96.70	85.90	115.01	—
	10.00	9.90	9.11	—
	106.70	95.80	124.11	—
	80.67	72.99	90.87	—
	41.25	39.87	48.14	—
	3.31	2.64	1.56	—
	16.78	15.92	14.74	—
	0.14	0.17	0.10	—
	2.34	2.14	2.01	—
	20.94	19.24	21.01	—
	26.03	22.80	33.24	—
	0.31	0.31	-0.77	—
	26.35	23.11	32.47	—
	7.12	6.73	8.31	—
	19.21	16.38	24.16	—
	68.84	45.85	67.61	—
Key metrics
	28.83	25.42	34.58	—
	29.81%	29.60%	30.10%	—
	19.87%	19.10%	21.00%	—
	—	10.90%	15.90%	—
	-5.36%	-25.30%	—	—
	7.26%	-32.20%	—	—
	—	-5.47	-4.16	—
	—	0.95	-0.05	—
	—	0.02	0.02	—
	—	2.96	0.15	—
	—	169.7	117.1	—
Balance sheet
	—	240.66	229.46	—
	—	176.97	176.55	—
	—	1.37	3.41	—
	—	29.43	33.64	—
	—	20.53	9.87	—
	—	19.24	18.83	—
	—	43.17	21.74	—
	—	10.02	6.62	—
	—	27.31	24.96	—
	—	4.33	3.56	—
	—	4.33	3.56	—
	—	0.00	0.00	—
	—	209.11	201.21	—
Cash flow
	—	15.62	-1.22	—
	—	-17.71	-0.15	—
	—	0.06	2.71	—
	—	21.09	2.94	—

Compounded growth

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): -5.36%
Profit YoY (TTM): +7.26%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 71.51%

Quarter	September 2026	June 2026
Promoter %	71.51%	71.51%

Holder	Type	Holding	Previous	Change
CHETAN NAVINCHANDRA DOSHI	Promoter	51.54%	51.54%	0.00%
Coral India Finance and Housing Limited	Promoter Group	19.97%	19.97%	0.00%
Investor Education And Protection Fund Authority Ministry Of Corporate Affairs	Public	2.63%	2.64%	-0.01%
MEETA SAMIR SHETH	Public	1.84%	1.84%	0.00%
Pooja Bhagwandas	Public	1.83%	1.83%	0.00%
NEELAM MITTAL	Public	1.14%	—	—
NOETIC FINANCE PRIVATE LIMITED	Public	1.06%	1.06%	0.00%
Navinchandra Bachubhai Doshi	Promoter	0.00%	0.00%	0.00%
Meera Chetan Doshi	Promoter Group	0.00%	0.00%	0.00%
Manav Chetan Doshi	Promoter Group	0.00%	0.00%	0.00%
Kundan Navinchandra Doshi	Promoter	0.00%	0.00%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
Coral Laboratories Ltd. S	174	486.20	9.04	10.90%	-5.36% TTM	+7.26% TTM	-1.68%

Filings & corporate actions

Recent announcements

Coral Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 ....4 Nov 2026 · Board Meeting / Board Meeting
Certificate under Reg. 74(5) of SEBI (DP) Regulation10 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Voting Results and Scrutinizer Report for AGM held on September 30, 202630 Sep 2026 · AGM/EGM / AGM
Proceedings of the 44th Annual General Meeting of the Company held on Tuesday, 29th September 202629 Sep 2026 · AGM/EGM / AGM
Closure of Trading Window25 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Considered and approved Cost Audit Report in CRA-3 for the financial year 2025-2625 Sep 2026 · Board Meeting / Outcome of Board Meeting
Coral Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/09/2026 ,inter alia, to consider and approve Intimation of Board meeting ....21 Sep 2026 · Board Meeting / Board Meeting
News paper Publication of dispatch of notice5 Sep 2026 · Company Update / Newspaper Publication
Annual report for the financial year 2025-264 Sep 2026 · Others / Reg. 34 (1) Annual Report
Notice of 44th AGM scheduled to be held on September 29, 2026.4 Sep 2026 · AGM/EGM / AGM
Copy of News paper Publication3 Sep 2026 · Company Update / Newspaper Publication
Notice of Book Closure14 Aug 2026 · Corp. Action / Book Closure
Intimation for holding 44th AGM14 Aug 2026 · AGM/EGM / AGM
Financial results for the quarter ended on June 30, 202614 Aug 2026 · Result / Financial Results
Record date for final dividend and Book Closure date14 Aug 2026 · Corp. Action / Record Date
Outcome of Board meeting14 Aug 2026 · Board Meeting / Outcome of Board Meeting
Newspaper publication on shares to be transferred to IEPF6 Aug 2026 · Company Update / Newspaper Publication
Coral Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve 1. Standalone unaudited ....5 Aug 2026 · Board Meeting / Board Meeting
Postal ballot e-voting results alongwith Scrutinizer''s Report23 Jul 2026 · AGM/EGM / Postal Ballot
Outcome of Postal ballot result alongwith Scrutinizer Report23 Jul 2026 · AGM/EGM / Postal Ballot
Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 201814 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Clarification with respect to query raised by BSE for movement in price25 Jun 2026 · Company Update / General
The Exchange has sought clarification from Coral Laboratories Ltd on June 24, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....24 Jun 2026 · Company Update / Clarification
Copies of Newspaper publications are attached23 Jun 2026 · Company Update / Newspaper Publication
Closure of Trading Window22 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Notice of Postal Ballot22 Jun 2026 · AGM/EGM / Postal Ballot
Outcome of Board meeting18 Jun 2026 · Company Update / General
Outcome of Board Meeting18 Jun 2026 · Others / Outcome without intimation
Final dividend of ? 2 per share30 May 2026 · Corp. Action / Dividend
Appointment of Cost Auditor30 May 2026 · Company Update / General
Appointment of Internal Auditor30 May 2026 · Company Update / General
The Board has approved ? 2 per share dividend.30 May 2026 · Corp Action / Dividend Updates
Results for the financial year ended on March 31, 202630 May 2026 · Result / Financial Results
Outcome of Board meeting held on May 30, 202630 May 2026 · Board Meeting / Outcome of Board Meeting
Annua Secretarial Compliance Report for the financial year ended March 31, 202630 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Board to consider Dividend20 May 2026 · Corp. Action / Dividend
Coral Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 ....20 May 2026 · Board Meeting / Board Meeting
Scrutinizer''s report on postal ballot e-voting results concluded on May 6, 2026.7 May 2026 · AGM/EGM / Postal Ballot
Outcome of Postal ballot e-voting results, concluded on May 6, 2026.7 May 2026 · AGM/EGM / Postal Ballot
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....30 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 2.0000	22 Sep 2026	22 Sep 2026	—
Final Dividend - Rs. - 1.5000	19 Sep 2025	19 Sep 2025	—
Final Dividend - Rs. - 2.0000	20 Sep 2024	—	—

Board meetings

14 Aug 2026 Board Meeting - Financial Results